Introduction
Pharmacovigilance is the science of monitoring, detecting, assessing, and preventing adverse drug reactions (ADRs) to ensure medicines are safe for public use.
Pharmacovigilance based on manual review of safety reports, clinical data, and post-marketing surveillance, which can be time-consuming and resource-intensive. With the increasing volume of healthcare data, Artificial Intelligence (AI) has emerged as a valuable tool to enhance pharmacovigilance activities.
1. Early Detection of Adverse Drug Reactions:
AI uses machine learning algorithms to analyze data from electronic health records, clinical trials, and safety databases.
It can detect patterns and identify ADRs earlier than traditional methods, allowing faster intervention and prevention of serious harm.
2. Automation of Safety Case Processing:
AI-powered systems use Natural Language Processing (NLP) to extract relevant information from medical reports and automatically code adverse events. This reduces manual workload, improves accuracy, and speeds up case processing.
3. Signal Detection and Risk Assessment:
AI can analyze multiple data sources, including medical literature and patient reports, to identify safety signals. It helps experts evaluate risks, frequency, and severity of ADRs, improving risk management strategies.
4. Predictive Analysis and Decision Support:
AI can predict potential adverse effects based on patient characteristics and drug profiles. This helps healthcare professionals make safer prescribing decisions and supports personalized medicine.
Conclusion
Artificial Intelligence is revolutionizing in pharmacovigilance by improving efficiency, accuracy, and early detection of drug safety issues. It reduces human workload, enhances signal detection, and supports better clinical decisions.
Can Artificial Intelligence become the future guardian of drug safety?
MBH/PS